Literature DB >> 6251148

Chromatographic characterization of adsrenocorticotrophin in human plasma.

S J Ratter, P J Lowry, G M Besser, L H Rees.   

Abstract

A chromatographic procedure has been developed for the characterization of ACTH- and lipotrophin- (LPH) related peptides in human plasma under acid-dissociating conditions to minimize artifacts of protein binding. The recovery and sensitivity of this method permits identification of ACTH at normal physiological levels in the circulation. Plasma profiles obtained from normal subjects and patients with pituitary dependent Cushing's disease, Addison's disease and Nelson's syndsrome showed only one significant peak of ACTH activity eluting in the position of purified native human 1--39 ACTH. However, the plasma profiles obtained from all the patients with the ectopic ACTH syndrome demonstrated a second peak of immunoreactive larger-molecular-weight ACTH and in some plasma samples this was the only form of ACTH observed. This larger-molecular-weight ACTH eluted midway between the void volume and 1--39 ACTH and co-eluted with a protein marker of molecular weight 22 000.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6251148     DOI: 10.1677/joe.0.0850359

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  9 in total

1.  Evidence for ectopic ACTH production years after bilateral adrenalectomy for Cushing's syndrome: in vivo and in vitro studies.

Authors:  M Boscaro; G Merola; N Sonino; A M Menegus; F Sartori; F Mantero
Journal:  J Endocrinol Invest       Date:  1985-10       Impact factor: 4.256

Review 2.  Corticotropin in human plasma. General considerations.

Authors:  M Schöneshöfer; H J Goverde
Journal:  Surv Immunol Res       Date:  1984

3.  Expression of pro-opiomelanocortin gene and quantification of adrenocorticotropic hormone-like immunoreactivity in human normal peripheral mononuclear cells and lymphoid and myeloid malignancies.

Authors:  R Buzzetti; L McLoughlin; P M Lavender; A J Clark; L H Rees
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

4.  Gel chromatographic characterization of immunoreactive adrenocorticotropin in patients with ACTH hypersecretion.

Authors:  M Reincke; B Allolio; U Deuss; W Winkelmann
Journal:  Klin Wochenschr       Date:  1989-11-03

5.  Limited clinical usefulness of plasma corticotropin-releasing hormone, adrenocorticotropin and beta-endorphin measurements as markers of lung cancer.

Authors:  A E Calogero; G Minacapilli; A M Nicolosi; M L Moncada; A Mistretta; S F Latteri; P Polosa; R D'Agata
Journal:  J Endocrinol Invest       Date:  1992-09       Impact factor: 4.256

6.  Ectopic ACTH secretion due to a bronchopulmonary carcinoid localized by somatostatin receptor scintigraphy.

Authors:  G Iser; M Pfohl; U Dörr; E M Weiss; F J Seif
Journal:  Clin Investig       Date:  1994-11

7.  Surgical management of the ectopic ACTH syndrome.

Authors:  C J Davies; G F Joplin; R B Welbourn
Journal:  Ann Surg       Date:  1982-09       Impact factor: 12.969

8.  Ectopic secretion of ACTH and met-enkephalin from a thymic carcinoid.

Authors:  J Baker; I M Holdaway; M Jagusch; A R Kerr; R A Donald; P T Pullan
Journal:  J Endocrinol Invest       Date:  1982 Jan-Feb       Impact factor: 4.256

9.  Circulating ACTH and related peptides in lung cancer.

Authors:  J G Ratcliffe; J Podmore; B H Stack; W G Spilg; C Gropp
Journal:  Br J Cancer       Date:  1982-02       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.